微信公众号

官网二维码
中国癌症防治杂志

中国癌症防治杂志 ›› 2025, Vol. 17 ›› Issue (2): 215-222.doi: 10.3969/j.issn.1674-5671.2025.02.13

• 综述 • 上一篇    下一篇

复发/转移性鼻咽癌治疗进展

  

  1. 贵州医科大学附属医院肿瘤科；贵州医科大学临床医学院肿瘤学教研室；贵州医科大学附属肿瘤医院肿瘤科
  • 出版日期:2025-04-25 发布日期:2025-05-15
  • 通讯作者: 金风 E-mail：jinf8865@yeah.net
  • 基金资助:
    国家自然科学基金计划项目（82060556）；贵州省卫生健康委科学技术基金项目（gzwkj2024?096；gzwkj2021?049）

Advance in treatment of recurrent/metastatic nasopharyngeal carcinoma

  • Online:2025-04-25 Published:2025-05-15

PDF (PC)

14

赞

摘要： 复发和转移是鼻咽癌死亡的主要原因之一，患者预后差且个体异质性大，总生存期有待提高。近年来，针对复发/转移性鼻咽癌治疗的研究较多，尤其是免疫治疗、靶向治疗及放射治疗在该领域均有不同进展，为患者提供了更多合理且有效的治疗方案。本文就复发/转移性鼻咽癌患者采取免疫、靶向、免疫联合靶向及放射治疗的当前研究进展进行综述。

关键词: 鼻咽癌, 复发, 转移, 免疫治疗, 靶向治疗, 放射治疗

Abstract: Recurrence and metastasis are the main causes of death in nasopharyngeal carcinoma, with poor prognosis for patients and significant individual variations, necessitating improvement in overall survival. In recent years, extensive research on the treatment of recurrent/metastatic nasopharyngeal carcinoma(R/M NPC), with notable advancements in immunotherapy, targeted therapy, and radiotherapy, providing patients more reasonable and effective treatment options. This review summarizes current progress on immunotherapy, targeted therapy, their combination, and radiotherapy for patients with R/M NPC.

Key words: Nasopharyngeal carcinoma, Recurrence, Metastasis, Immunotherapy, Targeted therapy, Radiotherapy

中图分类号: 

  • 739.62